These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30326304)

  • 1. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
    Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
    World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and future of relapsed primary central nervous system lymphoma (PCNSL).
    Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA
    Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
    Bairey O; Taliansky A; Glik A; Amiel A; Yust-Katz S; Gurion R; Zektser M; Porges T; Sarid N; Horowitz NA; Shina TT; Lebel E; Cohen A; Geiger KR; Raanani P; Wolach O; Siegal T
    Cancer; 2023 Dec; 129(24):3905-3914. PubMed ID: 37572086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study.
    Erkurt MA; Berber I; Tekgündüz E; Dogu MH; Korkmaz S; Demir C; Yilmaz M; Akay OM; Pala C; Bilen Y; Kaya E; Sari I; Sencan M; Kuku I; Altuntaş F; Dal MS; Aydogdu I
    Transfus Apher Sci; 2016 Feb; 54(1):80-4. PubMed ID: 26810141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).
    Kuitunen H; Tokola S; Siniluoto T; Isokangas M; Sonkajärvi E; Alahuhta S; Turpeenniemi-Hujanen T; Jantunen E; Nousiainen T; Vasala K; Kuittinen O
    J Neurooncol; 2017 Jan; 131(2):293-300. PubMed ID: 27752883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
    Houillier C; Soussain C; Ghesquières H; Soubeyran P; Chinot O; Taillandier L; Lamy T; Choquet S; Ahle G; Damaj G; Agapé P; Moluçon-Chabrot C; Amiel A; Delwail V; Fabbro M; Jardin F; Chauchet A; Moles-Moreau MP; Morschhauser F; Casasnovas O; Gressin R; Fornecker LM; Abraham J; Marolleau JP; Tempescul A; Campello C; Colin P; Tamburini J; Laribi K; Serrier C; Haioun C; Chebrek S; Schmitt A; Blonski M; Houot R; Boyle E; Bay JO; Oberic L; Tabouret E; Waultier A; Martin-Duverneuil N; Touitou V; Cassoux N; Kas A; Mokhtari K; Charlotte F; Alentorn A; Feuvret L; Le Garff-Tavernier M; Costopoulos M; Mathon B; Peyre M; Delgadillo D; Douzane H; Genet D; Aidaoui B; Hoang-Xuan K; Gyan E
    Neurology; 2020 Mar; 94(10):e1027-e1039. PubMed ID: 31907289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
    Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
    Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
    Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
    Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
    Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral intraventricular primary central nervous system lymphoma (LIPCNSL): a review.
    Yang J; Liu Z; Yang Y; Chen H; Xu J
    QJM; 2020 Jul; 113(7):457-464. PubMed ID: 31899520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years.
    Shibamoto Y; Tsuchida E; Seki K; Oya N; Hasegawa M; Toda Y; Takemoto M; Sumi M; Hiratsuka J; Oguchi M; Hosono M; Yasuda S; Sougawa M; Kakutoh Y; Hayabuchi N
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):351-6. PubMed ID: 15034788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Stem Cell Transplantation in Central Nervous System Lymphoma: A Multicenter Retrospective Series and a Review of the Literature.
    Dholaria BR; Kumar A; Azzuqua AG; Nishihori T; Kharfan-Dabaja MA; Tun HW; Ayala E
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e273-e280. PubMed ID: 30914301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
    Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
    Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.
    Kasenda B; Ihorst G; Schroers R; Korfel A; Schmidt-Wolf I; Egerer G; von Baumgarten L; Röth A; Bloehdorn J; Möhle R; Binder M; Keller U; Lamprecht M; Pfreundschuh M; Valk E; Fricker H; Schorb E; Fritsch K; Finke J; Illerhaus G
    Leukemia; 2017 Dec; 31(12):2623-2629. PubMed ID: 28559537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.